Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors

Histone deacetylase inhibitors (HDIs) are promising anticancer therapies and have been clinically used for the treatment of hematological malignancy. However, their efficacy in solid tumors is marginal and drug resistance hampers their further clinical utility. To develop novel strategies for the HD...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncogene
Main Authors: Lee, Su-Chan, Min, Hye-Young, Jung, Hyun Jin, Park, Kwan Hee, Hyun, Seung Yeob, Cho, Jaebeom, Woo, Jong Kyu, Kwon, So Jung, Lee, Hyo-Jong, Lee, Ho-Young
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069101/
https://ncbi.nlm.nih.gov/pubmed/27086926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2016.92
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares